Back

ESMO Plenary Mar 2023 - ESMO Virtual Plenaries: Mar 2023

Mar 27 - Mar 28, 2023 | LuganoSwitzerland

LARVOL is not affiliated with ESMO Virtual Plenaries: Mar 2023 and all trademarks, logos, and brand names are property of their respective owners

Top Trials
Condition
Product
MOA
Trial Name/ID

Showing 1 titles linked to Trials

Dostarlimab+chemotherapy for the treatment of primary advanced or recurrent (A/R) endometrial cancer (EC): A placebo (PBO)-controlled randomised phase III trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

8 Twitter Reactions